Press "Enter" to skip to content

Asieris Announces Completion of Enrollment for its US APL-1202 Phase Ib Clinical Trial – Yahoo Finance

admin 0

Asieris Announces Completion of Enrollment for its US APL-1202 Phase Ib Clinical Trial  Yahoo Finance

SHANGHAI, June 24, 2019 /PRNewswire/ — Asieris, a China-based biotech company specializing in the development and commercialization of new drugs for …

“bladder cancer” – Google News

(Visited 1 times, 1 visits today)

Leave a Reply

Your email address will not be published. Required fields are marked *